Transplantation-induced ischemia/reperfusion injury in the rat heart.
Novartis Pharma AG, Basel, Switzerland.
M
M
Bigaud
P
P
Gfeller
S
S
Deveze
G
G
Vogt
J P
JP
Evenou
C
C
Bruns
H G
HG
Zerwes
D000241:Adenosine; D000493:Allopurinol; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D003080:Cold Temperature; D003402:Creatine Kinase; D016166:Free Radical Scavengers / Q000494:pharmacology; D005978:Glutathione; D006321:Heart; D016027:Heart Transplantation / Q000502:physiology*; D007328:Insulin; D019157:Ischemic Preconditioning, Myocardial; D008297:Male; D017202:Myocardial Ischemia; D015428:Myocardial Reperfusion Injury; D019188:Organ Preservation Solutions; D010477:Perfusion / Q000379:methods; D011092:Polyethylene Glycols / Q000494:pharmacology; D011281:Pregnatrienes / Q000494:pharmacology; D011887:Raffinose; D051381:Rats; D017208:Rats, Wistar; D013482:Superoxide Dismutase / Q000494:pharmacology; D013997:Time Factors
D000975:Antioxidants; D016166:Free Radical Scavengers; D007328:Insulin; D019188:Organ Preservation Solutions; D011281:Pregnatrienes; C055206:University of Wisconsin-lactobionate solution; D011092:Polyethylene Glycols; D000493:Allopurinol; D013482:Superoxide Dismutase; C063471:polyethylene glycol-superoxide dismutase; D003402:Creatine Kinase; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose; C053355:tirilazad